Aurobindo Pharma USA, a subsidiary of Aurobindo Pharma, has entered into a definitive agreement to acquire Lannett from Lannett Seller Holdco for $250 million on a cash-free, debt-free basis.
The acquisition of Lannett Company in the US by Aurobindo Pharma will provide the drug-maker a strong manufacturing base in the US at a time when tariffs on imports into the US have become a concern ...
TREVOSE, Pa.--(BUSINESS WIRE)--Lannett Company, Inc. (the “Company” or “Lannett”) today announced that it and certain of its subsidiaries have successfully emerged from their Chapter 11 cases ...
Generic drugmaker Lannett Company Inc filed for bankruptcy after saying it reached a tentative deal to hand control of the business to lenders and cut debt. The Trevose, Pennsylvania-based firm listed ...
Lannett Company, Inc. announced that it has recently sold previously discontinued abbreviated new drug applications for approximately $3 million to a privately held pharmaceutical company. -Companies ...
Lannett is one step closer to launching biosimilar insulin glargine. Recently, the company completed subject dosing in the pivotal clinical trial of biosimilar insulin glargine, a product being ...
Lannett reveals earnings for the most recent quarter on February 3. Analysts predict losses per share of $0.320. Watch Lannett stock price move in real-time ahead here. On February 3, Lannett reveals ...
Generic drug maker Lannett is shuttering the Silarx liquid drug production plant it bought in 2015 and letting go of 72 workers at the Carmel, New York, facility. News of the closure and layoffs at ...
The generic-drug maker gets ejected from a top small-cap stock index. Lannett became a component the S&P SmallCap 600 index in 2014. It hasn't been a popular stock lately, falling by 33% since the ...
Shares of Lannett Co. Inc. gained 7.3% in premarket trading on Wednesday after the company said it received feedback from the Food and Drug Administration about the ongoing development of a biosimilar ...
Generic drug manufacturer Lannett (NYSE: LCI) released its financial results for the second quarter of its fiscal year 2021 -- which ended on Dec. 31, 2020 -- after the market closed on Wednesday. And ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback